Correction to: Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study

Detalles Bibliográficos
Autores principales: Cui, Yuzhong, Huang, Wei, Du, Feng, Yin, Xiaoyang, Feng, Lei, Li, Baosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873746/
https://www.ncbi.nlm.nih.gov/pubmed/36473995
http://dx.doi.org/10.1007/s12094-022-03020-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9873746/
https://www.ncbi.nlm.nih.gov/pubmed/36473995
http://dx.doi.org/10.1007/s12094-022-03020-5

Ejemplares similares